1 perate South Atlantic using an original flow
cytometric (
14)CO2-tracer approach.
2 Immunohistochemical and flow
cytometric analyses demonstrated that prednisolone treat
3 Moreover, flow
cytometric analyses for B-cell markers revealed an MDM2-
4 Flow
cytometric analyses further confirmed that over-expressi
5 Our multicolor flow
cytometric analyses of human decidual leukocytes detecte
6 Flow
cytometric analyses of human fibrocytes (CD45(+) and col
7 Virtually digested" WSI enabled quantitative
cytometric analyses of individual cells displayed in a v
8 Notably, flow
cytometric analyses of lung CD8(+) T cells revealed a sh
9 zed by immunohistochemistry, along with flow
cytometric analyses of lymphocytes for iNOS expression a
10 AFIA versus clodronate-treated mice and flow
cytometric analyses of myeloid lineage cells in the bone
11 Flow
cytometric analyses on dendritic cells (DCs) in vitro an
12 Cell numbers were adequate to perform flow
cytometric analyses on T cell lineage, T cell activation
13 Finally, flow
cytometric analyses revealed that IL-15 increases the pr
14 Flow
cytometric analyses showed significant accumulation of M
15 Flow
cytometric analyses showed that the susceptibility of EC
16 microglia within tissue sections and by flow
cytometric analyses.
17 at various times after immunization for flow
cytometric analyses.
18 the traditional sample-by-sample approach in
cytometric analysis and highlight the need for scalable
19 7-H4 protein expression was examined by flow
cytometric analysis and immunohistochemical staining.
20 and cytokine profiles were assessed by flow
cytometric analysis and multiplex assay.
21 Flow-
cytometric analysis and quantitative real-time polymeras
22 ddress this, we combined multiparameter flow
cytometric analysis and T-cell subpopulation sorting wit
23 Flow
cytometric analysis and Western blots showed that blocki
24 By flow
cytometric analysis at early times during infection, nei
25 A parallel flow
cytometric analysis confirmed the electrochemical result
26 Flow
cytometric analysis demonstrated an expanded CD19+ CD5+
27 Flow
cytometric analysis found elevated renin content in prin
28 Flow
cytometric analysis indicated GPR18 deficiency more stro
29 Flow
cytometric analysis indicated that treatment with caper
30 as evidenced by a mammosphere assay and flow
cytometric analysis of aldehyde dehydrogenase 1 (ALDH1)
31 Flow
cytometric analysis of basophil responses implied labeli
32 ts with AAV and 19 healthy controls for flow
cytometric analysis of CD4+ T cell populations.
33 utational algorithms have been developed for
cytometric analysis of cells and proteins in subcellular
34 Flow
cytometric analysis of cells from rectal biopsy specimen
35 cell cycle and apoptosis studies using flow
cytometric analysis of cellular DNA content.
36 Flow
cytometric analysis of CNS-infiltrating mononuclear cell
37 Ex vivo flow-
cytometric analysis of DENV-specific CD4(+) T cells reve
38 in lymphocytes were quantified through flow
cytometric analysis of H2AX phosphorylation (gamma-H2AX)
39 Using flow
cytometric analysis of harvested MKs, we show that while
40 Fluidigm BioMark and multiparameter flow
cytometric analysis of HIV-specific cytolytic CD4+ T cel
41 chain-reaction (qPCR) assay, as well as flow-
cytometric analysis of IgG antibody responses against tw
42 Flow
cytometric analysis of Il17a(-/-)Apoe(-/-) and Il17ra(-/
43 or vehicle, tumour load was measured by flow
cytometric analysis of infiltrated spleens, and subclona
44 Flow
cytometric analysis of ischemic muscles at day 2 reveale
45 Flow
cytometric analysis of lung cells revealed that the numb
46 Flow
cytometric analysis of lung tissue from H2 R-deficient a
47 Flow
cytometric analysis of lymphocytes in the blood, lymph n
48 Flow
cytometric analysis of microglial cells obtained from in
49 Flow
cytometric analysis of MOLT-4 cells treated with EERB sh
50 Flow
cytometric analysis of multiple organs, including the ki
51 Flow
cytometric analysis of mutant Lkt-treated PMNs revealed
52 rimental allergen challenge model, with flow
cytometric analysis of nasal curettage samples, to asses
53 Flow
cytometric analysis of NPs (n = 9) showed that 5.1% +/-
54 Flow
cytometric analysis of peripheral blood B cells of 30 MC
55 thy subjects were included for 11-color flow
cytometric analysis of peripheral blood for IgG4-express
56 Here, flow
cytometric analysis of peripheral blood mononuclear cell
57 nced pan-lymphopenia as demonstrated by flow
cytometric analysis of peripheral blood.
58 Flow-
cytometric analysis of primary human NK cells as well as
59 Using flow
cytometric analysis of resected adenomatous parathyroid
60 livary flow measurement, histologic and flow
cytometric analysis of salivary glands, and serum antinu
61 We used flow
cytometric analysis of sinonasal mucosal tissues of 29 C
62 Flow
cytometric analysis of splenocytes from infected mice re
63 Similarly, flow
cytometric analysis of stromal cells revealed a signific
64 Flow
cytometric analysis of SUSD3-knockdown cells revealed bl
65 Flow
cytometric analysis of synaptosome preparations was used
66 pheral blood samples were processed for flow
cytometric analysis of T-cell populations.
67 Flow
cytometric analysis of tetramer-reactive B cell subsets
68 Flow
cytometric analysis of the cell cycle demonstrated an in
69 Flow
cytometric analysis of the ocular infiltrate in WT mice
70 Flow
cytometric analysis of tumor-infiltrated macrophages sho
71 Flow
cytometric analysis on the collected samples found that
72 Flow
cytometric analysis revealed 3 distinct neutrophil popul
73 Flow
cytometric analysis revealed 97.9%+/-1.5% and 94.3%+/-5.
74 Flow
cytometric analysis revealed a significant reduction of
75 Flow-
cytometric analysis revealed increased numbers of regula
76 Flow
cytometric analysis revealed significant enrichment for
77 Flow
cytometric analysis revealed significant reduction of fr
78 Flow
cytometric analysis revealed that a sizable sub-populati
79 Flow
cytometric analysis revealed that the percentage of PD-1
80 Flow
cytometric analysis revealed that upregulation of CD95 e
81 Flow
cytometric analysis reveals the presence of a higher con
82 Flow
cytometric analysis showed a 41.7% increase in the mean
83 Flow
cytometric analysis showed aFP treatment elicited an inc
84 Flow
cytometric analysis showed alterations in tumor-infiltra
85 Flow
cytometric analysis showed impairment of erythroid diffe
86 Flow
cytometric analysis showed that CD1a(+) cells in NPs mig
87 is decreased plaque macrophage content, flow
cytometric analysis showed that the numbers of circulati
88 Edu-labelled flow
cytometric analysis showed that the percentage of the Ed
89 Flow
cytometric analysis showed the increase in IFN-gamma cor
90 Flow
cytometric analysis shows that both the location and act
91 Finally, a
cytometric analysis shows that the TREM1 rs6910730(G) al
92 B cell ELISpot and flow
cytometric analysis suggest that short-term fostamatinib
93 Flow
cytometric analysis suggested that Ifitm3(-/-) macrophag
94 Ex vivo flow
cytometric analysis supported a direct effect of myeloma
95 l in vitro affinity selections based on flow
cytometric analysis that allows fine quantitative discri
96 Here, through flow
cytometric analysis the small-molecule macrocycle cyclot
97 ssue explants and optimized a method of flow
cytometric analysis to directly quantify infection rates
98 Flow
cytometric analysis was used to investigate the origin o
99 Flow
cytometric analysis was used to monitor immune cell freq
100 By using flow
cytometric analysis, enzyme and receptor inhibitors, and
101 onfirmed by fluorescence microscopy and flow-
cytometric analysis, whereas cell cycle effects are only
102 ral blood mononuclear cell samples with flow
cytometric analysis.
103 ication of single platelet depletion by flow
cytometric analysis.
104 mmunoblotting, immunocytochemistry, and flow
cytometric analysis.
105 e antigen-DR (HLA-DR), and subjected to flow
cytometric analysis.
106 from NPs and matched blood samples for flow
cytometric analysis.
107 e examined by 7-amino-actinomycin D and flow
cytometric analysis.
108 to type 1 alveolar epithelial cells by flow
cytometric analysis.
109 ) and increased the S-phase fraction by flow
cytometric analysis.
110 Circulating MSCs were quantified by flow
cytometric analysis.
111 (HSPCs) were decreased in NHD13 mice by flow
cytometric analysis.
112 on therapy underwent a liver biopsy for flow
cytometric analysis.
113 ndirect immunofluorescence staining and flow-
cytometric analysis.
114 Both flow
cytometric and antibody-mediated neutralization studies
115 With histological, flow
cytometric and functional analyses, we find that CPCs re
116 ha expression patterns were examined by flow
cytometric and immunofluorescence analysis.
117 nly based on single-cell analysis as in flow
cytometric and microfluidic cell sorters.
118 Phagocytic uptake was detected using flow
cytometric and microscopic techniques.
119 In this study, we developed flow
cytometric and T cell enzyme-linked immunosorbent spot (
120 Both flow
cytometric and transcriptomic analysis indicated stimula
121 Herein we used detailed transcriptomic, flow
cytometric,
and functional analysis and transcription fa
122 s of lungs were assessed by histologic, flow
cytometric,
and quantitative PCR analysis.
123 d 25 healthy subjects using an 11-color flow
cytometric antibody panel.
124 d 27 healthy subjects using an 11-color flow
cytometric antibody panel.
125 lines coupled with RNA interference and flow
cytometric approaches, we find that transforming growth
126 In this study, we report a sensitive flow
cytometric assay based on magnetic pre-enrichment of CD1
127 it binding of PPS-specific B cells in a flow
cytometric assay demonstrating specificity and functiona
128 Here we evaluate a 7-hour flow
cytometric assay for assessing Treg function, using supp
129 We have developed a flow
cytometric assay for inflammasome formation, time of fli
130 his study, we used a recently developed flow
cytometric assay for the direct ex vivo characterization
131 s volume (MCV) and reticulocytosis; the flow-
cytometric assay showed good correlation with the spectr
132 elease assay (IGRA) was combined with a flow
cytometric assay that detects induction of CD25(+)CD134(
133 Using a Click-iT flow
cytometric assay to directly measure mitotic protein syn
134 We developed a flow
cytometric assay to profile CD1-restricted T cells ex vi
135 We developed a flow-
cytometric assay to study membrane protein-protein inter
136 A simple, high-throughput flow
cytometric assay was developed that uses THP-1 cells and
137 We have used an optimized flow
cytometric assay, based on the analysis of unfixed brain
138 he spectrophotomeric assay and the G6PD flow-
cytometric assay.
139 ctivation of leukocytes was assessed by flow
cytometric assays and by immunofluorescence microscopy.
140 We then used flow
cytometric assays capable of measuring total and Ag-spec
141 Flow
cytometric assays combined with intra-vital imaging indi
142 ombination of genetic, biochemical, and flow
cytometric assays in conjunction with a mathematical mod
143 paramagnetic resonance spectroscopy and flow
cytometric assays showed a significant increase in cellu
144 Apoptotic
cytometric assays showed that pretreatment of CSCs with
145 This was confirmed by
cytometric assays showing that inactive compounds failed
146 Rapid, sensitive, and highly specific flow-
cytometric assays were developed for the detection of th
147 As judged from flow
cytometric assays, bacterial killing by GA occurred with
148 ested using the lymphoproliferation and flow
cytometric assays.
149 LISA, Luminex, quantitative RT-PCR, and flow
cytometric assays.
150 Flow
cytometric assessment and mathematical modeling of intra
151 d by interferon (IFN)-gamma ELISpot and flow
cytometric assessment of directly H-2K reactive cells.
152 t is possible by simple histological or flow
cytometric assessments.
153 A single-cell based approach called
cytometric bar coding (CyBar) for fast identification of
154 ecay rapidly to pMHC monomers, allowing flow-
cytometric-
based measurements of monomeric TCR-pMHC diss
155 production by polyp cells was determined by
cytometric bead array (CBA) and intracellular cytokine a
156 We developed a novel
cytometric bead array for assessment of antigen-specific
157 4, IL-5, IL-10 and IL-13 were quantified via
cytometric bead array in plasma.
158 Additionally, cytokines were measured by
cytometric bead array, and L-ficolin was measured in bro
159 ee supernatants were quantified by using the
cytometric bead array, and mRNA expression of transcript
160 A
cytometric bead array, ELISA, and intracellular cytokine
161 rescein diacetate succinimidyl ester dye and
cytometric bead array, formed an in vitro surrogate mark
162 t model, together with immunohistochemistry,
cytometric bead array, functional adhesion and migration
163 protein signatures were determined by ELISA,
cytometric bead array, or quantitative PCR.
164 n with mitogenic, TLR, and T-cell stimuli by
cytometric bead array.
165 on was assessed in supernatants by using the
Cytometric Bead Array.
166 evels of CCL11 were measured in plasma using
Cytometric Bead Array.
167 cytokines/chemokines were determined with a
cytometric bead array.
168 Cytokines in sera were analyzed by
cytometric bead array.
169 in-6 and interleukin-10 concentrations using
cytometric bead array.
170 ll responses by enzyme-linked immunospot and
cytometric bead array.
171 e cell culture was measured with the help of
cytometric bead arrays or ELISA assays.
172 n malaria (IL-5 and RANTES) were assessed by
cytometric bead assay in April 2008, October 2008, and A
173 asmodium falciparum antigens was assessed by
cytometric bead assay or enzyme-linked immunosorbent ass
174 IPAL FINDINGS: MCP-1 protein was measured by
cytometric bead assay.
175 We enrolled 27 patients whose median flow
cytometric calculated panel reactive antibody (CPRA) was
176 ly, we developed a rapid multiparameter flow
cytometric CBU potency assay that enumerates cells expre
177 Flow
cytometric cell cycle analysis of HUVECs treated with Ss
178 A combination of flow
cytometric cell sorting and deep sequencing of the 16S r
179 ecology was explored through combining flow
cytometric cell sorting and molecular techniques to dete
180 ere used for immunostaining in situ and flow
cytometric cell sorting.
181 Flow
cytometric characterization of Ag-specific T cells typic
182 between 1980 and 2013 that include the flow
cytometric characterization of leukocyte subsets in the
183 n, we performed detailed functional and mass
cytometric cluster analysis of multiple CD8(+) T-cell cl
184 ients with COA were determined by using flow
cytometric coexpression of collagen I, CD45, and CD34 or
185 Flow
cytometric counts revealed that exposure of human macrop
186 p; 76.3% for recipients with a positive flow-
cytometric cross-match but a negative cytotoxic cross-ma
187 ay for anti-HLA antibody but a negative flow-
cytometric cross-match versus 65.0% for the waiting-list
188 ible and had a negative or low-positive flow
cytometric crossmatch (+XM).
189 reened for human antibody binding using flow
cytometric crossmatch (FCXM).
190 rossmatch (CDC-XM) and donor cell-based flow
cytometric crossmatch (flow-XM) but low level DSA (i.e.,
191 detected by single antigen beads and B flow
cytometric crossmatch (XM).
192 t in B4GALNT2 genes were examined using flow
cytometric crossmatch assay.
193 alues have been found to correlate with flow
cytometric crossmatch results.
194 el was insufficient to cause a positive flow
cytometric crossmatch.
195 Flow
cytometric crossmatching (FXM) is a standard method to a
196 ), was developed and applied to analyze flow
cytometric data of bacterial responses to antibiotic exp
197 e 3-dimensional differences between the flow
cytometric data of the no-antibiotic treated bacteria an
198 When flow
cytometric data on mixtures of cell populations are coll
199 The presentation of high-dimensional
cytometric data using One-SENSE showed a significant imp
200 uencing or after careful examination of flow
cytometric data, as in the reports of lymphocyte-specifi
201 nts and blind multicenter reanalysis of flow
cytometric data, resulting in an unprecedented concordan
202 inds of multivariate data sets, such as flow
cytometric data, to identify differentially expressed po
203 ng the complexity and information content of
cytometric data.
204 nformation contained in a highly dimensional
cytometric dataset.
205 We used a stepwise approach for flow
cytometric detection and purification of human IgE-expre
206 These results and flow
cytometric detection of CD45 and CD127 suggest the prese
207 EBV-specific T cells were quantified by flow
cytometric detection of intracellular interferon-gamma a
208 We demonstrate that flow
cytometric detection of poorly differentiated basal tumo
209 rescein labeled folic acid was used for flow
cytometric detection of the expression of functional fol
210 l LT-HSC has been defined as FLT3(-) by flow
cytometric detection, we demonstrate that FLT3 is capabl
211 rane assays amenable to high-throughput flow
cytometric detection.
212 Modern-era molecular and flow-
cytometric diagnostic methods are very sensitive and can
213 F, AMD3100 or ischemia was evaluated by flow
cytometric enumeration of circulating Lin(-)Sca-1(+)cKit
214 were harvested at these time points for flow
cytometric evaluation of immune cell subtypes and immuno
215 , therapeutic antibodies may complicate flow
cytometric evaluation of normal and neoplastic plasma ce
216 However, both the flow
cytometric evaluation of the TCR-Vbeta repertoire on CD4
217 re normal or only slightly reduced, and flow
cytometric evaluations of the TCR-Vbeta repertoires of t
218 We report the flow
cytometric (
FC) identification and characterization of l
219 reformed DSA detected by single-antigen flow
cytometric fluorescent beads (SAFBs).
220 reformed DSA detected by single-antigen flow
cytometric fluorescent beads (SAFBs).
221 We identified by flow
cytometric,
fluorescent microscopic, immunoblot, and mas
222 Here we sought to develop a flow
cytometric gating strategy to reliably identify blood Ig
223 Myeloid cells were characterized in flow
cytometric,
histologic, and immunohistochemical analyses
224 describe a fluorescence-based multiplex flow-
cytometric host cell reactivation assay (FM-HCR) that me
225 Using a fluorescence-based multiplex flow
cytometric host cell reactivation assay that provides si
226 eveloped a fluorescence-based multiplex flow-
cytometric host cell reactivation assay wherein the acti
227 We describe a protocol for flow
cytometric identification of viral reservoirs, based on
228 Multiplexed, phenotypic, intravital
cytometric imaging requires novel fluorophore conjugates
229 servations were more deeply analyzed by flow
cytometric imaging, confocal imaging, and measurement of
230 T cells were purified and subjected to flow
cytometric immune-phenotyping and functional assays.
231 le, rapid, multi-parametric assay using flow
cytometric immunofluorescence to reveal interactions amo
232 ate protein-DNA binding is monitored by flow
cytometric immunofluorescence, which allows for accurate
233 proliferative, we applied comprehensive flow
cytometric immunophenotyping and functional assays of cy
234 To date, flow
cytometric immunophenotyping has not been used to invest
235 CD45 barcoding facilitates accuracy of mass
cytometric immunophenotyping studies, thus supporting bi
236 ipts or breakpoints, and multiparameter flow
cytometric immunophenotyping.
237 ined single-cell functional assays with flow
cytometric index sorting and single-cell gene expression
238 In this article, we report a flow
cytometric investigation of B lymphocyte subpopulations
239 tive isolation, complex multi-parameter flow
cytometric isolation of phenotypic subsets has facilitat
240 In conclusion, flow
cytometric LPT represents a reliable and useful method f
241 We established a flow
cytometric lymphocyte proliferation test (LPT) for the d
242 Flow
cytometric membrane integrity staining demonstrated the
243 The development of a flow-
cytometric method allowed us to identify hemophagocytes
244 the infected host, we developed a novel flow
cytometric method for measuring lysosome damage.
245 In this study we present a flow
cytometric method identifying HBEC as CD45 negative, EpC
246 we describe a 2-d, 96-well plate-based flow
cytometric method of micronucleus scoring that is simple
247 Vs, we used nanoFACS, a high-resolution flow
cytometric method that utilizes light scattering and flu
248 ave developed, validated, and applied a flow
cytometric method that will be useful to interrogate the
249 To date, a flow
cytometric method to identify HBEC recovered from lower
250 Emerging high-resolution
cytometric methods have created a pressing need for effi
251 Cytometric methods revealed extensive neutrophilic infil
252 ge groups of patients with CHB and used flow
cytometric methods to measure production of effector and
253 51 meningioma samples by multiparameter flow
cytometric (
MFC) immunophenotyping and investigated the
254 motherapy sensitivity by multiparameter flow
cytometric minimal residual disease (MFC-MRD) detection
255 Cytometric monitoring of microbial community dynamics ca
256 We compared the BM flow
cytometric,
morphologic, and cytogenetic features of 28
257 Here we established an assay based on flow
cytometric multiparameter assay assessing expression of
258 D38 core gating systems and an 11-color flow
cytometric panel were used to determine the frequencies
259 PSFC the fluorescence lifetime is taken as a
cytometric parameter to differentiate intracellular even
260 the flexibility of employing a wide range of
cytometric parameters for identifying colonies and cells
261 differences between sample and control flow
cytometric populations, even in a label-free scheme with
262 table after treatment, correlating with flow
cytometric presence or absence of circulating M-PCs.
263 subjects using targeted multiparameter flow
cytometric profiling of NK cell phenotypes and functions
264 ent cell barcoding with high-throughput flow
cytometric profiling of primary and metastatic colon can
265 Here we show, using transcriptional and
cytometric profiling of whole blood collected before vac
266 ografting, and multiplexed phospho-flow (PF)
cytometric profiling to study drug response and identify
267 ngle-cell genomic, transcriptional, and mass-
cytometric profiling, it remains a challenge to collect
268 erived microparticles by a standardized flow
cytometric protocol in 119 patients referred for stress
269 +) regulatory T cells were subjected to flow
cytometric quantification and sorting followed by qRT-PC
270 tries, the fixation conditions, and the flow
cytometric quantification methods used.
271 y of human cells to HAP was examined by flow
cytometric quantification of apoptotic cell death and de
272 Phosphoflow
cytometric quantification of p70S6K phosphorylation may
273 ce resonance energy transfer (FRET) and flow
cytometric quantification.
274 Flow
cytometric quantitation indicated that GPVI dimers accou
275 s in adhesion receptor expression using flow
cytometric quantitation of integrins and l-selectin memb
276 ed, as detected using a high-throughput flow
cytometric quantum dot Forster resonance energy transfer
277 expressing P. falciparum antigens and a flow
cytometric readout of infection, we are able to robustly
278 Dual-laser flow
cytometric resonance energy transfer (FCET) is a statist
279 uorescent probes were investigated in a flow
cytometric screen of ABC transporters.
280 ss-reactive peptide ligand for a duplex flow
cytometric screen of FPR1 and FPR2 in color-coded cell l
281 of-principle study, we used comparative flow
cytometric screening to identify ICAM-1 as a potential t
282 n alpha-and beta-cells were obtained by flow
cytometric sorting after intracellular staining with c-p
283 ere phenotyped and isolated by means of flow
cytometric sorting from 18 patients at baseline and 13 p
284 rmal and fibrotic livers via subsequent flow
cytometric sorting, thus providing a validated method to
285 ed protocol that eliminated the need of flow
cytometric sorting.
286 ls purified by either bead selection or flow
cytometric sorting.
287 Using both coimmunoprecipitation and flow-
cytometric strategies, we found a bidentate interaction
288 Here, we developed a flow-
cytometric strategy capable of detecting membrane protei
289 Flow
cytometric studies showed that PGN enhanced the secretio
290 Flow
cytometric studies using monoclonal antibodies show that
291 Cytometric studies utilizing flow cytometry or multi-wel
292 ge segmentation, provides a means to conduct
cytometric studies while at the same time preserving cru
293 confirmed in structural, serologic, and flow-
cytometric studies.
294 dances and functions of cellular subsets via
cytometric studies.
295 This in vivo
cytometric technique may be useful in a wide range of st
296 the statistical accuracy of traditional flow
cytometric techniques to label-free biophysical biomarke
297 ned by fasting blood glucose levels and flow
cytometric techniques were used to test for donor-specif
298 chniques, including novel molecular and flow
cytometric technologies used for the determination of mi
299 We review these
cytometric technologies, capable of high-content, high-t
300 type of these cells were measured using flow
cytometric whole-blood assays.